Sayfa

YAYIN LİSTESİ:

1. Uluslararası hakemli dergilerde yayımlanan makaleler

SCI ve SCI expanded tarafından taranan uluslararası hakemli dergilerde yayınlanan makaleler:

      A1.    Ramalingam SS, Vansteenkiste J, Planchard D, Cho BC, Gray JE, Ohe Y, Zhou C, Reungwetwattana T, Cheng Y, Chewaskulyong B, Shah R, Cobo M, Lee KH, Cheema P, Tiseo M, John T, Lin MC, Imamura F, Kurata T, Todd A, Hodge R, Saggese M, Rukazenkov Y, Soria JC; FLAURA Investigators. (......Sriuranpong V, Yildiz R, Bondarenko I…..,) Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC. N Engl J Med. 2020 Jan 2;382(1):41-50.  doi: 10.1056/NEJMoa1913662.

      A2.    Schmidinger M, Bamias A, Procopio G, Hawkins R, Sanchez AR, Vázquez S, Srihari N, Kalofonos H, Bono P, Pisal CB, Hirschberg Y, Dezzani L, Ahmad Q, Jonasch E; PRINCIPAL Study Group (....Wyendaele W, Yildiz R, Yucel I...). Prospective Observational Study of Pazopanib in Patients with Advanced Renal Cell Carcinoma (PRINCIPAL Study)Oncologist. 2019 Apr;24(4):491-497. doi: 10.1634/theoncologist.2018-0787.

      A3.    Soria JC, Ohe Y, Vansteenkiste J, Reungwetwattana T, Chewaskulyong B, Lee KH, Dechaphunkul A, Imamura F, Nogami N, Kurata T, Okamoto I, Zhou C, Cho BC, Cheng Y, Cho EK, Voon PJ, Planchard D, Su WC, Gray JE, Lee SM, Hodge R, Marotti M, Rukazenkov Y, Ramalingam SS; FLAURA Investigators (Boyer M,…. Yildiz R,…..Nguyen N.) Osimertinib in Untreated EGFR-Mutated Advanced Non-Small-Cell Lung Cancer. N Engl J Med. 2018 Jan 11;378(2):113-125. doi: 10.1056/NEJMoa1713137.

      A4.    Yalçın Ş, Yildiz R, Dane F, Karaoğlu A, Öksüzoğlu B, Özyılkan Ö, Sevinç A, Özdemir F, Turna H, Uslu R, Ulay E. A national, multicenter, non-interventional, observational study on treatment patterns in patients with metastatic renal cell carcinoma in Turkey - NOTES study. Onco Targets Ther. 2018 Mar 5;11:1223-1228. doi: 10.2147/OTT.S148917.

      A5.    Choueiri TK, Escudier B, Powles T, Mainwaring PN, Rini BI, Donskov F, Hammers H, Hutson TE, Lee JL, Peltola K, Roth BJ, Bjarnason GA, Géczi L, Keam B, Maroto P, Heng DY, Schmidinger M, Kantoff PW, Borgman-Hagey A, Hessel C, Scheffold C, Schwab GM, Tannir NM, Motzer RJ; METEOR Investigators (Tan H, ……., Yildiz R, ……. Randall J.). Cabozantinib versus Everolimus in Advanced Renal-Cell Carcinoma. N Engl J Med. 2015 Nov 5;373(19):1814-23. doi: 10.1056/NEJMoa1510016. Epub 2015 Sep 25.

      A6.    Dinc NS, Aydın K, Odabas H, Ercelep O, Tufan G, Seker M, Yasar N, Aydin D, Yuksel S, Mert A, Ozcelik M, Korkmaz T, Yildiz R, Aliustaoglu M, Mayadagli A, Dane F, Gumus M. Pretreatment PET/CT Standardized Uptake Values Play a Role in Predicting Response to Treatment and Survival in Patients with Small Cell Lung Cancer. Oncol Res Treat. 2016;39:130-4. doi: 10.1159/000444272.

      A7.    Aydil U, Akmansu M, Gumusay Ö, Bakkal FK, Yazıcı Ö, Kızıl Y, Köybaşıoğlu A, Yıldız R, Büyükberber S, İnal E. Comparison of three different concurrent chemoradiation regimens for treatment of laryngeal cancer. Eur Arch Otorhinolaryngol. 2016;273:2795-803. doi: 10.1007/s00405-015-3854-8.

      A8.    Tonyali O, Coskun U, Yuksel S, Inanc M, Bal O, Akman T, Yazilitas D, Ulas A, Kucukoner M, Aksoy A, Demirci U, Uysal M, Tanriverdi O, Gunaydin Y, Sumbul AT, Yildiz R, Karaca H, Oksuzoglu B, Ciltas A, Buyukberber S, Benekli M; Anatolian Society of Medical Oncology (ASMO). Risk factors for brain metastasis as a first site of disease recurrence in patients with HER2 positive early stage breast cancer treated with adjuvant trastuzumab. Breast. 2016;25:22-6. doi: 10.1016/j.breast.2015.11.006.

      A9.    Algin E, Ozet A, Gumusay O, Yilmaz G, Buyukberber S, Coskun U, Baykara M, Cetin B, Yıldız R, Benekli M. Liver metastases from adenocarcinomas of unknown primary site: management and prognosis in 68 consecutive patients. Wien Klin Wochenschr. 2015 Sep 15. [Epub ahead of print]

     A10.   İnal A, Kos FT, Algın E, Yıldız R, Berk V, Unek İT, Colak D, Dane F, Geredeli C, Isıkdogan A. Prognostic factors for gemcitabine-refractory patients with advanced pancreatic cancer: a retrospective analysis of a multicentre study (Anatolian Society of Medical Oncology). Contemp Oncol (Pozn). 2015;19(2):125-9. doi: 10.5114/wo.2014.43933. Epub 2015 May 13.

     A11.   Gumusay O, Cetin B, Ozet A, Demirci U, Buyukberber S, Coskun U, Algin E, Uner A, Yildiz R, Kurt G, Benekli M. Factors predicting recurrence in patients with grade III glial tumors: impact of adjuvant temozolomide on recurrence. J BUON. 2014 Oct-Dec;19(4):1035-40.

     A12. Unal OU, Oztop I, Kos T, Assoc, Turan N, Kucukoner M, Helvaci K, Berk V, Sevinc A, Yildiz R, Cinkir Hy, Tonyali O, Demirci U, Aktas B, Balakan O, Yilmaz AU. Prognostic factors and adjuvant treatments for surgically treated cancers of the biliary tract: a multicentre study of the Anatolian Society of Medical Oncology (ASMO). Asian Pac J Cancer Prev. 2014;15(22):9687-92.

     A13. Rordorf T, Hassan AA, Azim H, Alexandru E, Er O, Gokmen E, Güral Z, Mardiak J, Minchev V, Peintinger F, Szendroi M, Takac I, Tesarova P, Vorobiof D, Vrbanec D, Yildiz R, Yücel S, Zekri J, Oyan B. Bone health in breast cancer patients: A comprehensive statement by CECOG/SAKK Intergroup.Breast. 2014 Jun 27. pii: S0960-9776(14)00096-4. doi: 10.1016/j.breast.2014.05.023. [Epub ahead of print] Review.

     A14. Yetisyigit T, Arpaci E, Seber ES, Kucukoner M, Kos FT, Sonmez OU, Alici S, Akman T, Aktas B, Yildiz R, Gunaydin Y, Inanc M, Demirci U, Alkis N, Gumus M. Salvage treatment experience in advanced synovial sarcoma: a multicenter retrospective analysis of the Anatolian Society of Medical Oncology. Asian Pac J Cancer Prev. 2013;14(9):5185-8.

     A15. Kefeli U, Benekli M, Sevinc A, Yildiz R, Kaplan MA, Ciltas A, Balakan O, Isikdogan A, Coskun U, Dane F, Harputluoglu H, Karaca H, Yazilitas D, Durnali A, Kaya AO, Demirci U, Gumus M, Buyukberber S. Efficacy of sorafenib in patients with gastrointestinal stromal tumors in the third- or fourth-line treatment: A retrospective multicenter experience. Oncol Lett. 2013 Aug;6(2):605-611. Epub 2013 Jun 17.

     A16. Tonyali O, Coskun U, Sener N, Inanc M, Akman T, Ulas A, Yazilitas D, Bal O, Kucukoner M, Yildirim Ozdemir N, Demirci U, Gunaydin Y, Yildiz R, Karaca H, Umit Unal O, Gumus M, Benekli M, Buyukberber S. Prognostic factors for recurrence-free survival in patients with HER2-positive early-stage breast cancer treated with adjuvant trastuzumab. Onkologie. 2013;36(10):554-8. doi: 10.1159/000355156. Epub 2013 Sep 16.

     A17. Uygun K, Bilici A, Kaya S, Oven Ustaalioglu BB, Yildiz R, Temiz S, Seker M, Aksu G, Cabuk D, Gumus M. XELIRI plus bevacizumab compared with FOLFIRI plus bevacizumab as first-line setting in patients with metastatic colorectal cancer: experiences at two-institutions. Asian Pac J Cancer Prev. 2013;14(4):2283-8.

     A18. Tonyali O, Benekli M, Berk V, Coskun U, Ozkan M, Yildiz R, Ucgul E, Sevinc A, Uncu D, Demirci U, Buyukberber S; Anatolian Society of Medical Oncology (ASMO). Efficacy and toxicity of Trastuzumab and Paclitaxel plus Capecitabine in the first-line treatment of HER2-positive metastatic breast cancer. J Cancer Res Clin Oncol. 2013 Jun;139(6):981-6. doi: 10.1007/s00432-013-1409-1. Epub 2013 Mar 5.

     A19. Kaplan MA, Isikdogan A, Gumus M, Arslan UY, Geredeli C, Ozdemir N, Koca D, Dane F, Suner A, Elkiran ET, Kucukoner M, Seker M, Helvaci K, Guler T, Uncu D, Inal A, Yildiz R. Childhood, adolescents, and young adults (≤25 y) colorectal cancer: study of Anatolian Society of Medical Oncology. J Pediatr Hematol Oncol. 2013 Mar;35(2):83-9. doi: 10.1097/MPH.0b013e31827e7f20.

     A20. Kaya AO, Gunel N, Benekli M, Akyurek N, Buyukberber S, Tatli H, Coskun U, Yildiz R, Yaman E, Ozturk B. Hypoxia inducible factor-1 alpha and carbonic anhydrase IX overexpression are associated with poor survival in breast cancer patients. J BUON. 2012 Oct-Dec;17(4):663-8.

     A21. Kaplan MA, Isikdogan A, Koca D, Kucukoner M, Gumusay O, Yildiz R, Dayan A, Demir L, Geredeli C, Kocer M, Arslan UY, Inal A, Akman T, Coskun U, Sener N, Inanc M, Elkiran ET, Ozdemir NY, Durnalı AG, Suner A, Alici S, Tarhan MO, Boruban C, Oksuzoglu B, Urakci Z. Clinical outcomes in patients who received lapatinib plus capecitabine combination therapy for HER2-positive breast cancer with brain metastasis and a comparison of survival with those who received trastuzumab-based therapy: a study by the Anatolian Society of Medical Oncology. Breast Cancer. 2013 Jan 19. [Epub ahead of print]

     A22. Kefeli U, Buyuberber S, Akyol M, Yildiz R, Kaplan MA, Ciltas A, Sevinc A, Karaca H, Seker M, Ozdemir N, Alacacioglu A, Coskun U, Isikdogan A, Dane F, Gumus M, Ozkan M, Suner A, Tarhan MO, Benekli M. Efficacy of sunitinib in Turkish patients with gastrointestinal stromal tumors; retrospective multicenter experience. Hepatogastroenterology. 2013 Jun;60(124):647-52.

     A23. Seker M, Sevinc A, Yildiz R, Cihan S, Kaplan MA, Gokdurnali A, Dane F, Yaman E, Karaca H, Colak D, Uyeturk U, Bilici A, Ozdemir NY, Kalender ME, Uncu D, Salepci T, Isikdogan A, Benekli M, Ozkan M, Gumus M, Coskun U, Camci C, Oksuzoglu B, Buyukberber S; Anatolian Society of Medical Oncology (ASMO). Prognostic factors in gastrointestinal stromal tumors: multicenter experience of 333 cases from Turkey. Hepatogastroenterology. 2013 Jun;60(124):768-75. doi: 10.5754/hge11666. Epub 2012 Nov 20.

     A24. Yildiz R, Benekli M, Ozkan M, Alkis N, Berk V, Kaplan MA, Ciltas A, Karaca H, Durnali AG, Coskun U, Dikilitas M, Sevinc A, Dane F, Yetisyigit T, Dogu GG, Buyukberber S. Bevacizumab every 4 week is as effective as every 2 weeks in combination with biweekly FOLFIRI in metastatic colorectal cancer. J Cancer Res Clin Oncol. 2012 Jun 22. DOI: 10.1007/s00432-012-1264-5.

     A25. Altinbas M, Kalender ME, Oven B, Sevinc A, Karaca H, Kaplan MA, Alici S, Arpaci E, Yildiz R, Uncu D, Camci C, Gumus M. Weekly topotecan for recurrent small cell lung cancer - a retrospective anatolian medical oncology group study. Asian Pac J Cancer Prev. 2012; 13: 2909-12.

     A26. Inal A, Ciltas A, Yildiz R, Berk V, Kos FT, Dane F, Unek IT, Colak D, Ozdemir NY, Buyukberber S, Gumus M, Ozkan M, Isikdogan A. Long term survivors with metastatic pancreatic cancer treated with gemcitabine alone or plus Cisplatin: a retrospective analysis of an anatolian society of medical oncology multicenter study. Asian Pac J Cancer Prev. 2012; 13: 1841-4.

     A27. Kefeli U, Yildirim ME, Aydin D, Madenci OC, Yasar N, Sener N, Mert AG, Yuksel S, Ercelep OB, Korkmaz T, Yildiz R, Gumus M. Netrin-1 concentrations in patients with advanced gastric cancer and its relation with treatment.Biomarkers. 2012 Aug 13. [Epub ahead of print]. Doi:10.3109/1354750X.2012.709882

     A28. Tonyali O, Coskun U, Sener N, Inanc M, Akman T, Oksuzoglu B, Ozdemir NY, Yazilitas D, Benekli M, Uner A, Yamac D, Demirci U, Yildiz R, Karaca H, Unal OU, Bal O, Gumus M, Buyukberber S; Anatolian Society of Medical Oncology (ASMO). Nine-week trastuzumab treatment versus 52-week trastuzumab treatment for HER2-positive early-stage breast cancer. J Cancer Res Clin Oncol. 2012 Aug 10. [Epub ahead of print]. DOI 10.1007/s00432-012-1296-x

     A29. Kaplan MA, Isikdogan A, Koca D, Kucukoner M, Gumusay O, Yildiz R, Dayan A, Demir L, Geredeli C, Kocer M, Arslan UY, Inal A, Unal OU, Mert AG, Bilici M, Ozkan M, Elkiran ET, Yaman S, Durnalı AG, Suner A, Alici S, Tarhan MO, Boruban C, Urakci Z, Buyukberber S. Biological subtypes and survival outcomes in breast cancer patients with brain metastases (study of the anatolian society of medical oncology). Oncology. 2012; 83: 141-50.

     A30.   Inal A, Kos FT, Algin E, Yildiz R, Berk V, Tugba Unek I, Colak D, Colak D, Kucukoner M, Tamer Elkiran E, Helvaci K, Geredeli C, Dane F, Balakan O, Ali Kaplan M, Gok Durnali A, Harputoglu H, Goksel G, Ozdemir N, Buyukberber S, Gumus M, Ozkan M, Benekli M, Isikdogan A; Anatolian Society Of Medical Oncology. Prognostic factors in patients with advanced pancreatic cancer treated with gemcitabine alone or gemcitabine plus cisplatin: retrospective analysis of a multicenter study. J BUON. 2012; 17: 102-5.

     A31.   Inal A, Kos FT, Algin E, Yildiz R, Dikiltas M, Unek IT, Colak D, Elkiran ET, Helvaci K, Geredeli C, Dane F, Balakan O, Kaplan MA, Durnali AG, Harputoglu H, Goksel G, Ozdemir N, Buyukberber S, Gumus M, Kucukoner M, Ozkan M, Uncu D, Benekli M, Isikdogan A. Gemcitabine alone versus combination of gemcitabine and cisplatin for the treatment of patients with locally advanced and/or metastatic pancreatic carcinoma: a retrospective analysis of multicenter study. Neoplasma. 2012; 59: 297-301.

     A32. Baykara M, Akkus M, Yildiz R, Gonul II, Dursun A, Coskun U, Benekli M, Sevinc A, Dane F, Buyukberber S. Survivin expression and its potential clinical significance in gastrointestinal stromal sarcoma. Int Immunopharmacol. 2011;11: 2227-31.

     A33. Sevinc A, Seker M, Bilici A, Ozdemir NY, Yildiz R, Ustaalioglu BO, Kalender ME, Dane F, Karaca H, Gemici C, Gumus M, Buyukberber S. Co-existence of gastrointestinal stromal tumors with other primary neoplasms. Hepatogastroenterology. 2011; 58: 824-30.

     A34. Budakoğlu B, Aksoy S, Arslan C, Uyetürk U, Babacan NA, Ozcan MF, Yıldız R, Oven BB, Ozdemir NY, Dizdar O, Buyukberber S, Akıncı MB, Türker I, Oksüzoğlu B, Altundag K, Zengin N. Frenquency of HCV infection in renal cell carcinoma patinents. Med. Oncol. 2012; 29: 1892-5.

     A35.   Kalender ME, Demiryürek S, Oztuzcu S, Kizilyer A, Demiryürek AT, Sevinc A, Dikilitas M, Yildiz R, Camci C. Association between the Thr431Asn polymorphism of the ROCK2 gene and risk of developing metastases of breast cancer. Oncol Res. 2010; 18: 583-91.

     A36.   Yildiz R, Coskun U, Buyukberber S, Sancak B, Kaya AO, Gulbahar O, Benekli M. Serum granulocyte colony-stimulating factor levels in gliomas. J BUON. 2011; 16: 138-41.

     A37.   Uncu D, Ozdemir NY, Aksoy S, Abali H, Oksuzoglu BC, Budakoglu B, Yildiz R, Aslan N, Zengin N. Adjuvant Bi-Weekly Combination of Cisplatin, Infusional 5-fluorouracil and Folinic Acid Followed by Concomitant Chemoradiotherapy with Infusional Fluorouracil for High Risk Operated Gastric and Gastroesophageal Junction Adenocarcinoma. Asian Pac J Cancer Prev. 2010; 11: 1493-7.

     A38.   Bahar B, Acedil Ayc Iota B, Coskun U, Büyükberber S, Benekli M, Yildiz R. Granulocyte colony stimulating factor (G-CSF) and macrophage colony stimulating factor (M-CSF) as potential tumor markers in non small cell lung cancer diagnosis. Asian Pac J Cancer Prev. 2010; 11: 709-12.

     A39.   Yildiz R, Benekli M, Buyukberber S, Kaya AO, Ozturk B, Yaman E, Berk V, Coskun U, Yamac D, Sancak B, Uner A. The effect of bevacizumab on serum soluble FAS/FASL and TRAIL and its receptors (DR4 and DR5) in metastatic colorectal cancer. J Cancer Res Clin Oncol. 2010; 136: 1471-6.

     A40.   Kaya AO, Buyukberber S, Dane F, Isikdogan A, Ustaalioglu BO, Coskun U, Yumuk PF, Dogu GG, Ozdemir NY, Sevinc A, Gumus M, Ozkan M, Yildiz R, Ozturk B, Yaman E, Benekli M; Anatolian Society of Medical Oncology. Cisplatin plus docetaxel combination in the first-line treatment of metastatic non-small cell lung cancer. Tumori. 2010; 96: 400-4.

     A41.   Kaya AO, Coskun U, Buyukberber S, Benekli M, Tekin E, Cifter C, Ozturk B, Yildiz R, Yaman E, Uner A, Yamac D. Efficacy and toxicity of preoperative chemotherapy with docetaxel and epirubicin in locally advanced invasive breast cancer. Journal of BUON. 2010; 15: 248-54.

     A42.   Yildiz R, Buyukberber S, Uner A, Yamac D, Coskun U, Kaya AO, Ozturk B, Yaman E, Benekli M. Bevacizumab plus irinotecan-based therapy in metastatic colorectal cancer patients previously treated with oxaliplatin-based regimens. Cancer Invest 2010; 28: 33-7.

     A43.   Yaman E, Buyukberber S, Benekli M, Oner Y, Coskun U, Akmansu M, Ozturk B, Kaya AO, Uncu D, Yildiz R. Radiation induced early necrosis in patients with malignant gliomas receiving temozolomide. Clin Neurol Neurosurg. 2010; 112: 662-7.

     A44.   Yaman E, Ozturk B, Coskun U, Buyukberber S, Kaya AO, Yildiz R, Benekli M. Synchronous bilateral breast cancer in an aged male patient. Onkologie 2010; 33: 255-8.

     A45.   Baykara M, Coskun U, Demirci U, Yildiz R, Benekli M, Cakir A, Buyukberber S. Intracystic papillary carcinoma of the breast: one of the youngest patient in the literature. Med Oncol 2009 ;27: 1427-8.

     A46.   Tonyali O, Coskun U, Yildiz R, Karakan T, Demirci U, Akyurek N, Benekli M, Buyukberber S. Imatinib mesylate-induced acute liver failure in a patient with gastrointestinal stromal tumors. Med Oncol. 2009; 27: 768-73.

     A47. Ozturk B, Coskun U, Yaman E, Akdemir O, Cakir A, Memis L, Sezer K, Kaya AO, Yildiz R, Demirci U, Benekli M, Oguz M, Buyukberber S. A case of extra-adrenal paraganglioma localized in retroperitoneum diagnosed with FDG-PET: Case report and review of the literature. The Endocrinologist 2010; 20: 60-2.

     A48. Demirci U, Büyükberber S, Yılmaz G, Oztürk B, Akyürek N, Yildiz R, Tonyalı O, Coşkun U, Benekli M. Coexistence Hodgkin's lymphoma and colonic adenocarcinoma: a case report. Med Oncol 2009; 27: 62-4.

     A49. Kaya AO, Buyukberber S, Benekli M, Coskun U, Sevinc A, Akmansu M, Yildiz R, Ozturk B, Yaman E, Kalender ME, Orhan O, Yamac D, Uner A; for Anatolian Society of Medical Oncology (ASMO). Concomitant chemoradiotherapy with cisplatin and docetaxel followed by surgery and consolidation chemotherapy in patients with unresectable locally advanced non-small cell lung cancer. Med Oncol 2009; 27: 152-7.

     A50. Ozturk B, Coskun U, Yaman E, Cakir A, Akdemir UO, Yildiz R, Akyol G, Demirci U, Buyukberber S, Tezer E, Benekli M. Adult hepatik epitheloid haemangioendothelioma presenting with Kasabach-Merrit syndrome: a case report. Journal of Clinical Pathology 2009; 62: 1053-5.

     A51. Kaya AO, Coskun U, Sancak B, Buyukberber S, Yildiz R, Gulbahar O, Benekli M, Ozenirler S. Increased serum granulocyte colony stimulating factor in Turkish hepatocellular carcinoma patients. Asian Pac J Cancer Prev 2009; 10: 403-6.

     A52. Coskun U, Alkis N, Celenkoglu G, Buyukberber S, Ozkan M, Camci C, Uner A, Er O, Aslan UY, Sevinc A, Tokluoglu S, Ozturk B, Yildiz R, Benekli M; Anatolian Society of Medical Oncology. Gemcitabine combined with uracil-tegafur in patients with advanced pancreatic cancer. J Natl Med Assoc 2009; 101: 761-4.

     A53. Kaya AO, Coskun U, Yildiz R, Gonul II, Karagulle K, Yaman E, Ozturk B. Primary pure smalll cell carcinoma of the urinary bladder which responded carboplatin plus etoposide regimen: A case report and review of the literature. Journal of BUON 2009; 14: 703-6.

     A54. Yildiz R, Benekli M, Akyurek N, Coskun U, Kaya AO, Ozturk B, Yaman E, Buyukberber S. Non-gestational uterine choriocarcinoma in a postmenopausal woman: a case report. Onkologie 2009; 32: 417-9.

     A55. Yaman E, Gonul II, Buyukberber S, Ozturk B, Akyurek N, Coskun U, Kaya AO, Yildiz R, Sare M, Kitapci M. Metastatic fibroblastic reticulum cell sarcoma of the liver: pathological and PET-CT evaluation. Pathology 2009; 41: 289-92.

     A56. Yaman E, Coskun U, Ozturk B, Buyukberber S, Kaya AO, Coskun O, Buyukberber N, Yildiz R, Benekli M. Opportunistic cytomegalovirus infection in a patient receiving temozolomide for treatment of malignant glioma. J Clin Neurosci 2009; 16: 591-2.

     A57. Ozturk B, Tacoy G, Coskun U, Yaman E, Sahin G, Buyukberber S, Yildiz R, Kaya AO, Topal S, Ozdemir M, Benekli M. Gemcitabine-induced acute coronary syndrome: a case report. Med Princ Pract 2009; 18: 76-80.

     A58. Kaya AO, Coskun U, Unlu M, Akdemir UO, Ozdemir NY, Zengin N, Benekli M, Yildiz R, Yaman E, Ozturk B, Gumus M, Uner A, Yamac D, Ucgul E, Buyukberber S. Whole body 18F-FDG PET/CT imaging in the detection of primary tumours in patients with a metastatic carcinoma of unknown origin. Asian Pac J Cancer Prev 2008; 9: 683-6.

     A59. Yaman E, Buyukberber S, Uner A, Coskun U, Yamac D, Ozturk B, Kaya AO, Yildiz R, Benekli M; Anatolian Society of Medical Oncology (ASMO). Carboplatin and oral cyclophosphamide combination after temozolomide failure in malignant gliomas. Tumori 2008; 94: 674-80.

     A60. Yaman E, Coskun U, Benekli M, Sozen S, Yamac D, Buyukberber S, Ozturk B, Kaya AO, Yildiz R, Tezel E. Coexistence of gastrointestinal stromal tumor (GIST) of the rectum and adenocarcinoma of the prostate in a patient with familial GIST. Onkologie 2008; 31: 697-9.

     A61. Kaya AO, Buyukberber S, Coskun U, Yildiz R, Ozturk B, Yaman E, Adisen E, Gureli M, Benekli M. Acute erythema and edematous skin reaction and ectropion following docetaxel in a patient with non-small cell lung cancer. Cutan Ocul Toxicol 2008; 27: 327-31.

     A62. Yaman E, Benekli M, Coskun U, Sezer K, Ozturk B, Kaya AO, Yildiz R, Uluoglu O, Buyukberber S. Intrasellar plasmacytoma: an unusual presentation of multiple myeloma. Acta Neurochir (Wien) 2008; 150: 921-4; discussion 924.

     A63. Yamac D, Ozturk B, Coskun U, Tekin E, Sancak B, Yildiz R, Atalay C. Serum YKL-40 levels as a prognostic factor in patients with locally advanced breast cancer. Adv Ther 2008; 25: 801-9.

     A64. Yaman E, Buyukberber S, Uner A, Coskun U, Akmansu M, Benekli M, Yamac D, Ozturk B, Kaya AO, Yildiz R, Ozkan S, Gunel N. Temozolomide in newly diagnosed malignant gliomas: administered concomitantly with radiotherapy, and thereafter as consolidation treatment. Onkologie 2008; 31: 309-13.

     A65. Coskun U, Kaya AO, Buyukberber S, Benekli M, Uner A, Dikilitas M, Ozturk B, Yildiz R, Ozkan S, Yaman E, Yamac D. Single agent gemcitabine in the second-line treatment of advanced non-small cell lung cancer after treatment with taxane + platinum regimens. Med Oncol 2008; 25: 133-6.

     A66. Berk V, Yildiz R, Akdemir UO, Akyurek N, Karabacak NI, Coskun U, Benekli M. Disseminated extranodal NK/T-cell lymphoma, nasal type, with multiple subcutaneous nodules: utility of 18F-FDG PET in staging. Clin Nucl Med 2008; 33: 365-6.

     A67. Yaman E, Benekli M, Coskun U, Ozturk B, Kaya AO, Yildiz R, Buyukberber S. Reply to the article "oral ibandronate is as active as intravenous zoledronic acid for reducing bone turnover markers in women with breast cancer and bone metastases" by J.-J. Body et al. (Ann Oncol 2007; 18: 1165-1171). Ann Oncol 2008; 19: 397-8; author reply 398.

     A68. Benekli M, Yildiz R, Uner A, Er O, Yamac D, Alkıs N, Coskun U, Camci C, Buyukberber S. Gemcitabine plus capecitabine combination in metastatic breast cancer patients previously treated with anthracyclines and taxanes. Oncology 2007; 72: 308-13.

     A69. Coskun U, Buyukberber S, Yaman E, Er O, Uner A, Ozkan M, Dikilitas M, Oguz M, Yildiz R, Benekli M. XELOX (capecitabine plus oxaliplatin) as neoadjuvant chemotherapy of unresectable liver metastases in colorectal cancer patients. Neoplasma 2008; 55: 65-70.

     A70. Uner A, Ozturk B, Benekli M, Coskun U, Kocak S, Kaya AO, Unsal D, Erekul S, Yaman E, Yildiz R, Buyukberber S. Synchronized primary breast osteosarcoma and contralateral benign cystosarcoma phyllodes: Radiological and pathological imaging. Breast J 2008; 14: 109-10.

     A71. Ozturk B, Buyukberber S, Akmansu M, Coskun U, Yamac D, Uner A, Yaman E, Yildiz R, Kaya AO, Bora H, Unsal D, Pak Y, Benekli M. The results of three different treatment modalities in patients with locally advanced nasopharyngeal carcinoma. Med Oncol 2008; 25: 269-73.

     A72. Yildiz R, Coskun U, Kapucu O, Kaya AO, Akdemir UO, Benekli M, Buyukberber S. F-18 FDG uptake due to acinetobacter infection cause misinterpretation of treatment response in a lymphoma patient. Clin Nucl Med. 2007; 32: 471-3.

     A73. Ozturk B, Buyukberber S, Coskun U, Yaman E, Yildiz R, Kaya AO, Oner Y, Benekli M. Solitary iris metastasis from breast cancer with dramatic course: case report. Med Oncol 2007; 24: 463-5.

     A74. Yaman E, Uner A, Er O, Coskun U, Buyukberber S, Dikilitas M, Polat M, Yamac D, Kaya AO, Yildiz R, Ozturk B, Benekli M. Capecitabine plus oxaliplatin (XELOX) in the treatment of chemotherapy-naïve patients with metastastic colorectal cancer. Med Oncol 2007; 24: 431-5.

     A75. Yildiz R, Coskun U, Kaya AO, Ozturk B, Yaman E. Digital ischemic changes after gemcitabine therapy in a patient with metastatic non-small-cell lung cancer.Ann Pharmacother 2007; 41: 901-2.

     A76. Yaman E, Coskun U, Buyukberber S, Ozturk B, Kaya AO, Yildiz R, Uner A, Yamac D, Benekli M. Persistent elevation of CA 19-9 in an apparently healthy 56-year-old woman. Lab Medicine 2007; 38: 485-6.

     A77. Yildiz R, Yildirim B, Karincaoglu M, Harputluoglu M, Hilmioglu F. Brain natriuretic peptide (BNP) in relation with severity of disease in non-alcoholic cirrhotic patients. J Gastroenterol Hepatol 2005; 20: 1115-20.

     A78. Ara C, Sogutlu G, Yildiz R, Kocak O, Isik B, Yilmaz S, Kirimlioglu V. Spontaneous small bowel perforations due to intestinal tuberculosis should not be repaired by simple closure. J Gastrointest Surg 2005; 9: 514-7.

     A79. Kuku I, Aydogdu I, Kaya E, Ali Erkurt M, Dikilitas M, Baydar M, Yildiz R. The early and long-term results of oral high-dose methylprednisolone treatment in adult patients with idiopathic thrombocytopenic purpura. Eur J Haematol 2005; 74: 271-2.

     A80. Sahin I, Taskapan H, Yildiz R, Kosar F. Cardiac tamponade as initial presentation of Sheehan’s Syndrome. Int J Cardiol 2004; 94:129-30.

     A81.   Harputluoglu MM, Kantarceken B, Karincaoglu M, Aladag M, Yildiz R, Ates M, Yildirim B, Hilmioglu F. Acute pancreatitis: an obscure complication of organophosphate intoxication. Hum Exp Toxicol 2003; 22: 341-3.

     A82.    Aydogdu I, Ozturan O, Kuku I, Kaya E, Sevinc A, Yildiz R. Bilateral transient hearing loss associated with vincristine therapy: case report. J Chemother 2000; 12: 530-2.

SCI ve SCI expanded kapsamında olmayan uluslararası hakemli dergilerde yayınlanan makaleler:

     A83.   Yildiz R, Kalender ME, Dane F, Sevinc A, Gumus M, Camci C, Alici S, Kaya AO, Yaman E, Ozturk B, Coskun U, Benekli M, Uncu D, Buyukberber S. Docetaxel combined with oral etoposide as second-line treatment for advanced gastric carcinoma after failure of platinum- and fluoropyrimidine-based regimens. J Oncol Pharm Pract 2009; 16: 173-8.

     A84.   Cetin B, Coskun U, Yildiz R, Buyukberber S, Baykara M, Benekli M. Acute cholecystitis in a patient with metastatic renal cell carcinoma treated with everolimus. J Oncol Pharm Pract. 2011; 17: 274-8.

B. Uluslararası bilimsel toplantılarda sunulan ve bildiri kitabında (Proceedings) basılan bildiriler :

B1.     Kaplan MA, Isikdogan A, Koca D, Kucukoner M, Gumussoy O, Yildiz R, Oztop I, Demir L, Geredeli C, Kocer M, Arslan UY, İnal A, Akman T, Coskun U, Sener N, Inanc M, Elkiran ET, Ozdemir NY, Durnalı AG, Suner A, Alici S. Lapatinib or trastuzumab? Which anti-HER2 treatment is more effective in the treatment of patients with HER2-positive breast cancer with brain metastases? An Anatolian Society of Medical Oncology Study. . J Clin Oncol 2010; 30(Suppl): abstr 638. Annual Meeting of American Society of Clinical Oncology, Chicago, IL, USA, June 2-6, (2012).

B2.     Seker M, Sevinc A, Bilici A, Ozdemir NY, Yildiz R, Ustaalioglu B, Dane F, Uncu D, Gemici C, Gumus M, Buyukberber S. Co-existence of gastrointestinal stromal tumors with other neoplasms. Annals of Oncology 2010; 21 (Suppl 6): P0099. World Gastrointestinal Oncology Congress, Barcellona, Spain.

B3.     Yildiz R, Coşkun U, Baglan T, Buyukberber S, Uner A, Erdem O, Yamac D, Benekli M. The relation between endoglin (CD 105), thrombospondin-1 and VEGFR-3 and treatment results in metastatic colorectal cancer patients treated with bevacizumab combinatio therapy. Annals of Oncology, 21 (Suppl 8), 218, 35^th ESMO Congress, Milano, Italy, Oct 08-12, (2010).

B4.     Ozturk B, Benekli M, Akdemir UO, Buyukberber S, Coskun U,  Uner A, Unlu M, Yamac D, Kitapci M, Yaman E, Yildiz R, Demirci U, Kaya AO, Kapucu O. The utility and prognostic value of positron emission tomography with fluorine-18-fluoro-2-d-glucose (FDG-PET) on patients with Hodgkin and non-Hodgkin lymphoma. J Clin Oncol 2010; 28(Suppl): abstr e18535. Annual Meeting of American Society of Clinical Oncology, Chicago, IL, USA, June 4-8, (2010).

B5.     Yildiz R, Cetin B, Buyukberber S, Alkıs N, Seven A, .Arslan UY, Yılmaz B, Coskun U, Kos FT, Ozturk B, Benekli M. The combination of lapatinib and capecitabine in patients with ErbB2-positive metastatic breast cancer. The Oncologist, International patient case forum abstract, 9, oral presentation at the ASCO annual meeting, Chicago, IL, USA, June 4-8, (2010).

B6.     Benekli M, Buyukberber S, Coskun U, Ozturk B, Demirci U, Yildiz R. Reversible elevation of liver function test with lapatinib and capecitabine treatment in a patient with metastatic breast cancer. The Oncologist, International patient case forum abstract, 149, Chicago, IL, USA, June 4-8, (2010).

B7.     Kaya AO,  Gunel N, Benekli M, Akyurek N, Buyukberber S, Tatli H, Coskun U, Yildiz R, Yaman E, Ozturk B. Association of hypoxia inducible factor-1 and carbonic anhydrase IX overexpression and survival in HER2/neu positive hormone-unresponsive breast cancer patients. J Clin Oncol 2009; 27(Suppl): abstr e22078. Annual Meeting of American Society of Clinical Oncology, Orlando, Florida, USA, May 28-June 2, 2009.

B8.     Yildiz R, Buyukberber S, Uner A, Yamac D, Coşkun U, Kaya AO, Ozturk B, Yaman E, Benekli M. Bevacizumab plus irinotecan-based therapy in metastatic colorectal cancer patients previously treated with oxaliplatin-based regimen. Annals of Oncology 2008; 19 (Suppl 5): 143. ESMO conference Lugano (ECLU), Lugano, Switzerland, July 3-6, 2008: 143.

B9.     Yaman E, Buyukberber S, Oner Y, Coskun U, Akinansu M, Ozturk B, Kaya AO, Yildiz R, Uncu D, Benekli M. Temozolamide induced early necrosis in patients receiving temozolamide concomitant to radiotherapy. Int J Radiat Oncol Biol Phys 2008; 72 (Suppl): S239. 50th Annual Meeting of the American-Society-for-Therapeutic-Radiology-and Oncology, Boston, MA, USA, September 21-25, 2008.

B10.  Kaya AO, Buyukberber S, Coskun U, Yildiz R, Yaman E, Ozturk, Kalender ME, Orhan O, Sevinc A, Benekli M. Efficacy and toxicity of concomitant chemoradiotherapy with docetaxel and cisplatin in unresectable locally advanced stage non-small cell lung cancer. Annals of Oncology 2008; 19 (Suppl 5): 140. ESMO conference Lugano (ECLU), Lugano, Switzerland, July 3-6, 2008: 140.

B11.  Yaman E, Yildiz R, Kaya AO, Ozturk B, Buyukberber S, Coskun U, Benekli M, Yamac D, Uner A. The results of Xelox (capecitabine plus oxaliplatin) in metastatic colorectal cancer: A single center experience. Annals of Oncology 2006; 17 (Suppl 9): 129. 31^st ESMO Congress, Istanbul, Turkey, September 29-October 3, 2006: 129.

B12.    Turan N, Sahin I, Kosar F, Taskapan C, Topal E, Yildiz R. Evaluation of sympatho-vagal balance in patients with subclinic hypothyroidism. 12^th ICE Congress, Lizbon, Portugal, September 3-4, 2004: P1354.

B13.    Ari F, Sahin I, Kosar F, Taskapan H, Gunen H, Yildiz R. Effect of obesity on P wave duration P wave dispersion. 13^th European Congress on Obesity, Prague, Czech Republic, May 26-29, 2004: S68.

C. Yazılan ulusal/uluslararası kitaplar veya kitaplarda bölümler :

C1. Kitap: Aydogdu İ, Kaya E, Kuku İ, Ateş F, Ulu R, Baydar M, Dikilitaş M, Çıkım K, Şerefhanoğlu K, Erkurt MA, Yıldız R. Klinik Hematoloji ve Onkoloji Atlası, 1. Baskı,  Sistem Ofset, Ankara, 2004.

D. Ulusal hakemli dergilerde yayımlanan makaleler :

SCI ve SCI expanded tarafından taranan uluslararası hakemli dergilerde yayınlanan makaleler:

D1.  Cetın B, Büyükberber S, Yilmaz IB, Yildiz R, Coşkun U, Beneklı M. Kaposi's sarcoma in patients with ulcerative colitis receiving immunosuppressive drugs: report of a case. Turk J Gastroenterol. 2011; 22: 621-5.

D2.  Çetın B, Büyükberber S, Yüksel M, Coşkun U, Yildiz R, Beneklı M. Metastasis of rectal cancer to soft tissue of the hand: an unusual case. Turk J Gastroenterol. 2011; 22: 229-30.

D3.  Demirci U, Buyukberber S, Yildiz R, Coskun U, Benekli M. Significance of Hormonal Treatment in Metastatic Breast Cancer. UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI   2010; 20: 186-9.

D4.  Kaya AO, Buyukberber S, Yamac D, Coskun U, Yildiz R, Yaman E, Ozturk B, Benekli M. Changes in hormone receptor and Her2 status after neoadjuvant chemotherapy in breast cancer.  Turkiye Klinikleri Tip Bilimleri Dergisi 2010; 30: 469-73.

D5.  Kaya AO, Buyukberber S, Yildiz R, Ozturk B, Karagulle K, Yaman E. Uterine leiomyosarcoma presenting with neurological symptoms: Differantial diagnosis. Turkiye Klinikleri Tip Bilimleri Dergisi 2009; 29: 281-4.

D6.  Öztürk B, Coskun U, Yaman E, Kaya AO, Yıldız R, Benekli M, Büyükberber S. Oral kanserlerin risk faktörleri, premalign lezyonlar ve kemoprevensiyon. Uluslararası Hematoloji-Onkoloji Dergisi 2009; 19: 117-26.

D7.  Kaya AO, Yildiz R, Ozturk B, Yaman E, Barit G, Coskun U, Uner A, Benekli M, Yamac D, Buyukberber S. Eş zamanlı skuamöz hücreli akciğer karsinomu ve rektum adenokarsinomu birlikteliği: Olgu sunumu. UHOD-Uluslararasi Hematoloji-Onkoloji Dergisi 2008; 18: 42-5.

D8.  Kaya AO, Benekli M,  Ozturk B, Yaman E, Yildiz R, Coskun U. A 59 year-old female with breast cancer patient presenting with lower extremity weakness.  Turk J Cancer. 2007; 37: 74-5.

SCI ve SCI expanded kapsamında olmayan ulusal hakemli dergilerde yayınlanan makaleler:

D9.  Yıldız R, Cindoruk M, Büyükberber S, Kaya AO, Yaman E, Öztürk B, Coşkun U, Benekli M. Eroziv gatritlerde CA 19-9, CEA, CA 72-4 düzeyleri. Gazi Tıp Dergisi. 2009; 20: 55-6.

D10.       Yıldız R, Benekli M, Coşkun U, Büyükberber S. Trastuzumab kardiyotoksisitesi. Remisyon Güncel Onkoloji Dergisi 2010; 12 (1): . Baskıda

D11.       Kaya AO, Yildiz R, Yaman E, Buyukberber S, Yamaç D, Üner A. Ischemic digital gangrene after bleomycine: A Case Report. Uluslarası Hematoloji-Onkoloji Dergisi. 2006; 16: 195-9.

D12.       Kuku İ, Kaya E, Erkurt MA, Dikilitaş M, Yıldız R, Orhan M, Görgel A, Aydoğdu İ. Malatya ve çevresi ABO ve Rh kan grubu dağılımı. İnönü Üniversitesi Tıp Fakültesi Dergisi 2004; 11: 213-5.

D13.       Kuku İ, Kaya E, Yıldız R, Harputluoğlu H, Aydoğdu İ, Gürakan F. Gaucher disease: two case report. Türkiye Tıp Dergisi 2002; 9: 158-61.

E. Ulusal bilimsel toplantılarda sunulan ve bildiri kitaplarında basılan bildiriler:

        Birçok ulusal toplantıda 200’ den fazla sözlü ve yazılı bildiri

F. Diğer yayınlar :                       

F1.  Çeviriler:

1.    Yıldız R, Yamaç D. Baş-boyun kanserinde kemoterapi bölümü, Baş ve boyun cerrahisi, Cummings Otolaringoloji, 4. baskı, 114-145, Güneş Tıp Kitabevleri,    Ankara, 2007.

2.    Yıldız R, Üner A. Jinekolojik kanserlerde kemoterapi bölümü, Güncel obstetrik ve jinekoloji tanı ve tedavi, 11. baskı, 903-915, Güneş Tıp Kitabevleri, Ankara, 2008.